Under the dual pressure of work and life, many young people from the 80s to the 90s have joined the "hair loss family" "gloriously". In order to save the hairline or not become a "Mediterranean", many people have embarked on a journey of seeking medical advice. The end result is that some people choose to plant hair because of the ineffectiveness of the stone. Perhaps what you didn't expect is that in view of the long time of hair transplant surgery and the cumbersome process, there are now special artificial intelligence implanting robots. In fact, in addition to hair transplants, intelligent surgical robots have appeared in many medical vertical fields. These intelligent surgical robots are playing an increasingly important role because of their excellent characteristics. Previously, smart surgical robots were generally launched by American technology companies. But nowadays, domestic intelligent surgical robots are also beginning to appear on the big stage. However, it is worth noting that on the road to localization of intelligent surgical robots, there are still many problems and obstacles to overcome. Intelligent surgical robots erupt in the world, landing in multiple scenes Artificial intelligence is very good at doing high-intensity and high repetition rates, so it is suitable for landing in medical surgical scenarios. For example, the hair transplant AI robot performs well in terms of the completeness and integrity of the hair follicle extraction, and greatly saves manpower. As far as the market for smart surgical robots is concerned, Da Vinci surgical robots are probably the most widely known. As a representative of minimally invasive surgery, this intelligent surgical robot has the characteristics of precision, less trauma and quick recovery, which can help doctors reach the level of detail that humans cannot achieve. For the time being, smart surgical robots are exploding on a global scale. According to Boston Consulting's estimates, the annual revenue of medical robots is 4 billion US dollars, and will reach 11.4 billion US dollars in 2020. The global market research firm TrendForce's biotechnology report "Global Surgical Robot Market Trends" points out that the global remote-controlled surgical robot market can grow to $9.3 billion in 2021. More importantly, the medical scene covered by intelligent surgical robots is also rapidly expanding. From the abdominal cavity to thoracic surgery, urology, head and neck surgery and even cardiac surgery, intelligent surgical robots are expanding their reach. However, we must also see that the current intelligent surgical robots are the most popular in developed countries. It is reported that the United States is the largest market for intelligent surgical robots, and the highest proportion of surgical operations, followed by Europe, Asia and other regions. Soon after the start of the country, the technical heritage is still in the accumulation period. Faced with the superior characteristics of the intelligent surgical robot itself and the craze caused by it, domestic related companies are also actively embracing this enthusiasm. But realistically speaking, at present, domestic medical robots are mainly guided by medical robots, dispensing robots, and intelligent consultation robots, and there are fewer intelligent surgical robots. This also means that the overall development of domestic intelligent surgical robots is lagging. Even now, the related products used by many large hospitals in China are imported Da Vinci surgical robots. Fortunately, however, domestic intelligent surgical robots are in the stage of technological accumulation, and related companies are actively promoting the evolution of technology. For example, the domestic "Scorpio" orthopedic surgery robot has evolved to the third generation. It is not only the only orthopedic surgery robot in the world that can perform limb, pelvic fracture and full-spine surgery, and was approved for marketing in November 2016. However, it must be noted that the landing of intelligent surgical robots requires a long period of market incubation. For example, the application scenario of the second-generation surgery of "Scorpio" is relatively simple, and only about ten units are sold. However, the intelligence level and clinical indication coverage of the third-generation intelligent surgical robot of "Scorpio" have been greatly improved, and the current market feedback is not bad. In addition, in mid-April this year, Baihui Weikang "Rui Mi" neurosurgery robot (Remebot) officially passed the CFDA three types of medical device examination, becoming the first officially approved neurosurgical robot in China. In late October of this year, Bai Hui Weikang announced the completion of the 130 million yuan C round of financing. This round of financing will focus on the marketing of neurosurgical robots and the development of other surgical robot product lines. Overall, domestic intelligent surgical robots currently have certain breakthroughs, but the overall is in the stage of technology accumulation. At this stage, it is indispensable to present a thick future. 100% localization, the best development direction of intelligent surgical robot With the efforts of related companies, domestic intelligent surgical robots are showing signs of rapid development. What is particularly noteworthy is that the foothold of domestic intelligent robots is to achieve 100% localization! In the first half of this year, we received 100 million yuan of A-round financing, which is a new generation of artificial intelligence minimally invasive surgical robots that are being developed independently for the clinical needs of domestic minimally invasive surgery. It is understood that the domestic independent intellectual property surgery robot developed by Borns is expected to be available in 2019. As for Huazhi Micro-Chuanglian, it is the only neurosurgery robot developer in China that realizes its core intellectual property rights. It completely evades the high dependence of surgical robots on foreign core component manufacturers. It is reported that CAS-R-2 has achieved 100% domestic R&D, all core components are manufactured in China, and 100% of core components of core components are controlled by domestic enterprises. The 100% localization of intelligent surgical robots enables related companies to have a full set of self-maintenance maintenance and calibration solutions to quickly respond to hospitals, doctors' equipment commissioning, maintenance and service requirements. In the end, the overall improvement of cost, supply chain and after-sales service will be realized. Perhaps in the next time, we will see more domestic intelligent surgical robots in domestic hospitals. At that time, a complete front-end diagnosis, imaging, intraoperative, postoperative and overall service system will be constructed. And those who can benefit will be tens of millions of people. Food Grade Diacetate,Food Grade Sodium Diacetate,Sodium Diacetate,Sodium Diacetate C4H7Nao4 Wuxi Yangshan Biochemical Co.,Ltd. , https://www.yangshanchem.com
Intelligent surgical robots have exploded in the world